{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:31:19Z","timestamp":1786728679147,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Myasthenia Gravis (MG) is a chronic fluctuating illness, due to the dysfunction of neuromuscular junction which is autoimmune in nature. The disease severely affects the Quality Of Life (QOL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The primary objective of our study was to assess the QOL in patients with MG using Short Form 36 (SF 36) and MGQOL 15 R (Hindi translated).The secondary objective was to assess the correlation of age, sex, illness duration, clinical characteristics, severity, and treatment with the QOL in MG patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>A cross sectional study of 55 MG patients was done to analyse and evaluate the clinical status using Hybrid Myasthenia Gravis Foundation of America (HMGFA), Myasthenia gravis composite score (MGCS) and The Myasthenia Gravis Activities of Daily Living (MG \u2013 ADL). QOL was assessed by SF 36 and Hindi version of Myasthenia Gravis Quality of Life 15 \u2013 Revised (MG-QOL15R) score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>78.2% patients had generalized MG. The mean MGC and MG-ADL scores were 5.27 and 3.29 (95% CI: 2.24 -4.34) respectively. The mean MGQOL15R score was 6.52 \u00b1 7.7 and the score correlated with the symptoms. The SF 36 scores were the best and the worst in the bodily pain (93.72 \u00b1 13.52) and general health subset (61.81 \u00b1 39.64) respectively. Except for steroid dose, there was no significant correlation between SF36 and other factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>QOL in MG was found to be affected due to the disease. The MGQOL 15 R scores correlated with the clinical features, remission or active status, steroid use and thymectomy. No Significant association was observed between MG QOL scores and various lab parameters and repetitive nerve stimulation (RNS) test results. Higher dose of steroid was associated with poor QOL, while thymectomy was associated with better QOL scores. MGQOL15R (Hindi) is a quick and simple tool to assess the QOL in MG patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_945_22","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T16:00:54Z","timestamp":1692979254000},"page":"441-446","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Profile and Quality of Life in Myasthenia Gravis Using MGQOL15 R(Hindi): An Indian Perspective"],"prefix":"10.4103","volume":"26","author":[{"given":"Ganeshgouda","family":"Majigoudra","sequence":"first","affiliation":[{"name":"Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Duggal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashish","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Koul","sequence":"additional","affiliation":[{"name":"Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet K.","family":"Todi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Roshan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mus.20030","article-title":"Clinical evaluation and management of myasthenia gravis","volume":"29","author":"Keesey","year":"2004","journal-title":"Muscle Nerve"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"553626","DOI":"10.3389\/fneur.2020.553626","article-title":"Determinants of quality of life in myasthenia gravis patients","volume":"11","author":"Szczudlik","year":"2020","journal-title":"Front Neurol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.21883","article-title":"The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis","volume":"43","author":"Burns","year":"2011","journal-title":"Muscle Nerve"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cen3.12180","article-title":"Japanese clinical guidelines for myasthenia gravis:Putting into practice","volume":"6","author":"Murai","year":"2015","journal-title":"Clin Exp Neuroimmunol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2012.06771.x","article-title":"Patient registries:Useful tools for clinical research in myasthenia gravis","volume":"1274","author":"Baggi","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis:The MG composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2106\/JBJS.O.00030","article-title":"Scoring the SF-36 in orthopaedics:A brief guide","volume":"97","author":"Laucis","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mus.25198","article-title":"International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r","volume":"54","author":"Burns","year":"2016","journal-title":"Muscle Nerve"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures:Report of the ISPOR task force for translation and cultural adaptation","volume":"8","author":"Wild","year":"2005","journal-title":"Value Health"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/0028-3886.43455","article-title":"Myasthenia gravis:A study from India","volume":"56","author":"Singhal","year":"2008","journal-title":"Neurology India"},{"key":"R12-20240828","first-page":"7","article-title":"Myasthenia gravis:Clinical spectrum and long term follow-up study","volume":"8","author":"Ashraf","year":"2005","journal-title":"Ann Indian Acad Neurol"},{"key":"R13-20240828","first-page":"20130","article-title":"Clinical-Immunological profile of myasthenia gravis-a tertiary care centre experience","volume":"5","author":"Chithra","year":"2017","journal-title":"JMSCR"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3126\/njn.v14i1.20659","article-title":"Clinical profile of patients with myasthenia gravis in a tertiary center of Nepal","volume":"14","author":"Ojha","year":"2017","journal-title":"Nepal J Neurosci"},{"key":"R15-20240828","first-page":"1","article-title":"A five-year retrospective study on the clinical profile of myasthenia gravis with ocular involvement in a tertiary hospital","volume":"13","author":"Fatima","year":"2019","journal-title":"J Clin Diagn Res"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/0028-3886.181542","article-title":"MG-QoL-15 scores in treated myasthenia gravis:Experience from a university hospital in India","volume":"64","author":"Kumar","year":"2016","journal-title":"Neurology India"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fimmu.2020.00707","article-title":"Muscle-specific kinase myasthenia gravis","volume":"11","author":"Borges","year":"2020","journal-title":"Front Immunol"},{"key":"R18-20240828","first-page":"53","article-title":"Clinical Profile of Patients with Myasthenia Gravis Admitted in a Tertiary Care Centre in India","volume":"20","author":"Byju","year":"2021","journal-title":"IOSR J Dent Med Sci (IOSR-JDMS)"},{"key":"R19-20240828","first-page":"933","article-title":"Clinical profile of myasthenia gravis","volume":"46","author":"Saha","year":"1998","journal-title":"J Assoc Phys India"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/aian.AIAN_243_19","article-title":"Disease severity assessment and short-term outcome in patients with myasthenia gravis","volume":"23","author":"Vemuri","year":"2020","journal-title":"Ann Indian Acad Neurol"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000431036","article-title":"Geographical distribution of myasthenia gravis in northern Europe-results from a population-based study from two countries","volume":"44","author":"Boldingh","year":"2015","journal-title":"Neuroepidemiology"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","article-title":"Myasthenia gravis (MG):Epidemiological data and prognostic factors","volume":"998","author":"Mantegazza","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/0972-2327.112466","article-title":"Clinical profile and outcome of myasthenic crisis in a tertiary care hospital:A prospective study","volume":"16","author":"Sharma","year":"2013","journal-title":"Ann Indian Acad Neurol"},{"key":"R24-20240828","first-page":"218","article-title":"Study of demographic, clinical, laboratory and electromyographic symptoms in Myasthenia Gravis patients referred to the neurology clinic of Rasoul Akram hospital in 2015","volume":"8","author":"Sadri","year":"2015","journal-title":"J Med Life"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mus.23398","article-title":"The MG-QOL15 Japanese version:validation and associations with clinical factors","volume":"46","author":"Masuda","year":"2012","journal-title":"Muscle &nerve"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder:a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_945_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:30:20Z","timestamp":1786725020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_945_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_945_22","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2022-11-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}